Cardiac Risk of Left-Sided Breast Radiotherapy in the Contemporary Era

Overview

A large Ontario cohort study found no significant difference in 15-year cardiovascular hospitalization or mortality between left- and right-sided breast radiotherapy patients. Small increases in heart failure and ischemic heart disease were observed after left-sided treatment, particularly in younger women and those receiving chemotherapy. These findings suggest modern radiotherapy techniques have largely mitigated major cardiac risks but residual risk remains in select subgroups.

Background

Radiotherapy is essential for breast cancer cure but historically raised concerns about cardiac injury, especially for left-sided tumors due to heart proximity. Cardiac risk is dose-dependent and influenced by radiation technique and patient baseline risk. Advances in planning and heart-sparing have reduced cardiac exposure, shifting the clinical question to identifying which patients remain at meaningful risk. Large, long-term studies using tumor laterality as a proxy for cardiac dose help clarify contemporary risk.

Data Highlights

Key Findings

• No significant difference in primary cardiovascular hospitalization or all-cause mortality between left- and right-sided EBRT over 15 years.
• Small but statistically significant increases in new heart failure and ischemic heart disease after left-sided EBRT in patients without baseline CVD.
• Recurrent cardiovascular hospitalizations were modestly higher after left-sided treatment.
• Subgroup analyses showed higher CVD hospitalization risk with left-sided EBRT in women <50 years and those receiving chemotherapy.
• Laterality was not associated with increased risk of acute myocardial infarction, stroke, coronary revascularization, or cardiovascular mortality.
• Modern radiotherapy techniques and heart-sparing approaches have reduced but not eliminated cardiac risk.

Clinical Implications

Clinicians should continue to recommend indicated radiotherapy for breast cancer, recognizing that contemporary left-sided EBRT carries minimal incremental cardiac risk for most patients. Attention to heart-sparing techniques and aggressive cardiovascular risk management is especially important in younger patients and those receiving chemotherapy, who may have higher susceptibility to radiation-related cardiac injury. Patient counseling should focus on individualized absolute risk rather than tumor laterality alone.

Conclusion

Contemporary photon radiotherapy for left-sided breast cancer does not significantly increase major cardiovascular events compared to right-sided treatment, though small residual risks remain in select subgroups. Personalized risk assessment and heart-sparing strategies remain key to optimizing long-term cardiovascular outcomes.

Related Resources & Content

1. Nakajima et al 2023 -- Cardiac Risk Associated with Radiotherapy for Left-Sided Breast Cancer
2. Darby et al 2013 -- Risk of ischemic heart disease in women after radiotherapy for breast cancer
3. Taylor et al 2019 -- Cardiac dose and risk of cardiovascular disease after breast cancer radiotherapy
4. Khan et al 2021 -- Advances in heart-sparing radiotherapy techniques
5. Kirkbride et al 2022 -- Contemporary cardiac outcomes after breast radiotherapy